News

Fierce Pharma41m
AbbVie’s Skyrizi retakes top TV ad spending spot for the first time all year
AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...
New Atlas59m
The Ozempic pill is on the way, but one big US company won't be making it
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...